According to the report from a cryolife representative, on (b)(6) 2015 a surgeon from (b)(6) mentioned a hero case in (b)(6) in which the hero 1003 stylet went through the heart wall during the procedure, which may have resulted in death.Later the same day, a pa-c also mentioned the case in (b)(6).Neither the surgeon nor the pa-c could recall the surgeon's name or hospital name in (b)(6) during the discussions.Date of incident is unknown as well.
|
According to the report from a cryolife representative, on (b)(6) 2015 a surgeon from (b)(6) mentioned a hero case in (b)(6) in which the hero 1003 stylet went through the heart wall during the procedure, which may have resulted in death.Later the same day, a pa-c also mentioned the case in (b)(6).Neither the surgeon nor the pa-c could recall the surgeon's name or hospital name in (b)(6) during the discussions.Date of incident is unknown as well.
|
According to the report, "on (b)(6) 2015 a surgeon mentioned a hero case in (b)(6) in which the stylet went through the heart wall during the procedure.He also said that cryolife may not be aware of the case in (b)(6) yet.Later the same day, a physicians assistant (pa) also mentioned the case in (b)(6).Neither the surgeon nor the pa could recall the surgeon's name or hospital name during the discussions.Date of incident is unknown as well." additional clarifying information regarding the event was requested from the surgeon who reported the case initially, but he was unable to provide further details regarding the alleged event other than it had occurred in (b)(6).The two cryolife representatives for the (b)(6) region, were contacted via phone on 02/25/2015 to inquire if they were aware of any reports regarding the alleged event.Neither representative had heard of anything that would allude to such an event.A clinical review was performed based on the available information.No information regarding the implanter, procedure, institution, or patient history and comorbidities are available.The instructions for use (ifu) gives specific and detailed guidance as to the implantation of the hero graft, including details regarding the use of the stylet and includes the following statement: "caution: do not advance the tip of the delivery stylet into the right atrium." death is a known risk of any surgical procedure.Additionally, the ifu list patient death as a potential post-operative complication with rates of 0%-1.9% for patient's receiving a hero graft.With the information available it is not possible to determine the relationship, if any, between the cause of death and the hero graft.However, the stylet does have a slightly pointed end so it is plausible that it could puncture the heart wall, which would cause bleeding and potential death.A medical review was performed based on the available information.According to the report, the stylet perforated the heart wall during implantation of a hero device.No other details regarding the event are known.The stylet is a rigid device with a sharp tip which could potentially perforate the heart wall if advanced too far.Adequate warning against advancing the stylet into the right atrium are provided in the ifu.
|